842 related articles for article (PubMed ID: 16255019)
21. Influence of human leucocyte antigen-DRB1 on the susceptibility to rheumatoid arthritis and on the production of anti-cyclic citrullinated peptide antibodies in a Portuguese population.
Ligeiro D; Fonseca JE; Abade O; Abreu I; Cruz M; Nero P; Cavaleiro J; Teles J; Trindade H; Caetano JM; Branco J
Ann Rheum Dis; 2007 Feb; 66(2):246-8. PubMed ID: 16793843
[TBL] [Abstract][Full Text] [Related]
22. Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.
Okada Y; Yamada R; Suzuki A; Kochi Y; Shimane K; Myouzen K; Kubo M; Nakamura Y; Yamamoto K
Arthritis Rheum; 2009 Dec; 60(12):3582-90. PubMed ID: 19950296
[TBL] [Abstract][Full Text] [Related]
23. Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles.
Verpoort KN; Cheung K; Ioan-Facsinay A; van der Helm-van Mil AH; de Vries-Bouwstra JK; Allaart CF; Drijfhout JW; de Vries RR; Breedveld FC; Huizinga TW; Pruijn GJ; Toes RE
Arthritis Rheum; 2007 Dec; 56(12):3949-52. PubMed ID: 18050209
[TBL] [Abstract][Full Text] [Related]
24. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
25. Immunogenetic risks of anti-cyclical citrullinated peptide antibodies in a North American Native population with rheumatoid arthritis and their first-degree relatives.
El-Gabalawy HS; Robinson DB; Hart D; Elias B; Markland J; Peschken CA; Smolik I; Montes-Aldana G; Schroeder M; Fritzler MJ; Cheang M; Oen K
J Rheumatol; 2009 Jun; 36(6):1130-5. PubMed ID: 19411392
[TBL] [Abstract][Full Text] [Related]
26. The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden.
Kokkonen H; Johansson M; Innala L; Jidell E; Rantapää-Dahlqvist S
Arthritis Res Ther; 2007; 9(3):R56. PubMed ID: 17553139
[TBL] [Abstract][Full Text] [Related]
27. Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study.
Hoppe B; Häupl T; Gruber R; Kiesewetter H; Burmester GR; Salama A; Dörner T
Arthritis Res Ther; 2006; 8(2):R34. PubMed ID: 16469113
[TBL] [Abstract][Full Text] [Related]
28. [Impact of citrullination upon antigenicity of fibrinogen].
Zhao Y; Tian X; Li ZG
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):628-32. PubMed ID: 20450789
[TBL] [Abstract][Full Text] [Related]
29. Association of smoking with the constitution of the anti-cyclic citrullinated peptide response in the absence of HLA-DRB1 shared epitope alleles.
Verpoort KN; Papendrecht-van der Voort EA; van der Helm-van Mil AH; Jol-van der Zijde CM; van Tol MJ; Drijfhout JW; Breedveld FC; de Vries RR; Huizinga TW; Toes RE
Arthritis Rheum; 2007 Sep; 56(9):2913-8. PubMed ID: 17763436
[TBL] [Abstract][Full Text] [Related]
30. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
Kapitány A; Szabó Z; Lakos G; Aleksza M; Végvári A; Soós L; Karányi Z; Sipka S; Szegedi G; Szekanecz Z
Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568
[TBL] [Abstract][Full Text] [Related]
31. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
[TBL] [Abstract][Full Text] [Related]
32. HLA-DRB1 and anti-cyclic citrullinated peptide antibody production in rheumatoid arthritis.
Senkpiehl I; Marget M; Wedler M; Jenisch S; Georgi J; Kabelitz D; Steinmann J
Int Arch Allergy Immunol; 2005 Aug; 137(4):315-8. PubMed ID: 15970640
[TBL] [Abstract][Full Text] [Related]
33. Expression of QK/QR/RRRAA or DERAA motifs at the third hypervariable region of HLA-DRB1 and disease severity in rheumatoid arthritis.
Khani-Hanjani A; Lacaille D; Horne C; Chalmers A; Hoar DI; Balshaw R; Keown PA
J Rheumatol; 2002 Jul; 29(7):1358-65. PubMed ID: 12136889
[TBL] [Abstract][Full Text] [Related]
34. Redefining the HLA and RA association: to be or not to be anti-CCP positive.
de Vries RR; Huizinga TW; Toes RE
J Autoimmun; 2005; 25 Suppl():21-5. PubMed ID: 16257178
[TBL] [Abstract][Full Text] [Related]
35. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
van der Woude D; Houwing-Duistermaat JJ; Toes RE; Huizinga TW; Thomson W; Worthington J; van der Helm-van Mil AH; de Vries RR
Arthritis Rheum; 2009 Apr; 60(4):916-23. PubMed ID: 19333951
[TBL] [Abstract][Full Text] [Related]
36. Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis.
Goëb V; Dieudé P; Daveau R; Thomas-L'otellier M; Jouen F; Hau F; Boumier P; Tron F; Gilbert D; Fardellone P; Cornélis F; Le Loët X; Vittecoq O
Rheumatology (Oxford); 2008 Aug; 47(8):1208-12. PubMed ID: 18535030
[TBL] [Abstract][Full Text] [Related]
37. Associations of HLA-DRB1 alleles with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in northern east part of Turkey.
Uçar F; Çapkin E; Karkucak M; Yücel B; Sönmez M; Alver A; Kaklikkaya N; Tosun M; Alemdaroğlu E; Solak M
Int J Rheum Dis; 2012 Dec; 15(6):538-45. PubMed ID: 23253237
[TBL] [Abstract][Full Text] [Related]
38. Association between beta2 adrenergic receptor polymorphisms and rheumatoid arthritis in conjunction with human leukocyte antigen (HLA)-DRB1 shared epitope.
Malysheva O; Pierer M; Wagner U; Wahle M; Wagner U; Baerwald CG
Ann Rheum Dis; 2008 Dec; 67(12):1759-64. PubMed ID: 18267980
[TBL] [Abstract][Full Text] [Related]
39. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis.
Cha S; Choi CB; Han TU; Kang CP; Kang C; Bae SC
Arthritis Rheum; 2007 May; 56(5):1454-63. PubMed ID: 17469103
[TBL] [Abstract][Full Text] [Related]
40. [Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: relation with clinical features, cytokines and HLA-DRB1].
Correa PA; Tobón GJ; Citera G; Cadena J; Schneeberger E; Camargo JF; Maldonado-Cocco JA; Anaya JM
Biomedica; 2004 Jun; 24(2):140-52. PubMed ID: 15495594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
